Argent Capital Management LLC Amgen Inc Transaction History

Argent Capital Management LLC

$3.53 Billion
Q3 2024

A detailed history of Argent Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Argent Capital Management LLC holds 93,310 shares of AMGN stock, worth $24.7 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

93,310

Previous 69,259 34.73%

Holding current value

$24.7 Million

Previous $21.6 Million 38.94%

% of portfolio

0.85%

Previous 0.64%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$309.38 - $337.38 $7.44 Million - $8.11 Million	24,051 Added 34.73%	93,310 $30.1 Million
Q2 2024 Jul 24, 2024	SELL	$262.75 - $319.31 $218,870 - $265,985	-833 Reduced 1.19%	69,259 $21.6 Million
Q1 2024 Apr 29, 2024	BUY	$268.87 - $324.56 $18.1 Million - $21.9 Million	67,362 Added 2467.47%	70,092 $19.9 Million
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $42,044 - $46,645	-180 Reduced 6.19%	2,730 $665,000
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $39,943 - $46,548	-180 Reduced 5.83%	2,910 $724,000
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $37,650 - $44,834	-174 Reduced 5.33%	3,090 $710,000
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $234 - $260	1 Added 0.03%	3,264 $830,000
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $395 - $485	2 Added 0.06%	3,263 $770,000
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $182 - $241	1 Added 0.03%	3,261 $661,000
Q2 2019 Aug 15, 2019	SELL	$166.7 - $195.41 $161,699 - $189,547	-970 Reduced 22.93%	3,260 $601,000
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $76,869 - $86,649	-425 Reduced 9.13%	4,230 $804,000
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $30,328 - $35,402	170 Added 3.79%	4,655 $906,000
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $831,025 - $936,871	4,485 New	4,485 $930,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argent Capital Management LLC with notifications on news.

Account

Argent Capital Management LLC Amgen Inc Transaction History